EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 11

Ensembl ID : ENSECRG00000011715
Gene Symbol: PSMD11
3 Cross references
282 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 12

Ensembl ID : ENSECRG00000017259
Gene Symbol: PSMD12
3 Cross references
222 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 13

Ensembl ID : ENSECRG00000000984
Gene Symbol: PSMD13
3 Cross references
224 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 14

Ensembl ID : ENSECRG00000006879
Gene Symbol: PSMD14
3 Cross references
215 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 2

Ensembl ID : ENSECRG00000005158
Gene Symbol: PSMD2
3 Cross references
224 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 6

Ensembl ID : ENSECRG00000015115
Gene Symbol: PSMD6
3 Cross references
214 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 7

Ensembl ID : ENSECRG00000016623
Gene Symbol: PSMD7
3 Cross references
248 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSECRG00000018068
Gene Symbol: PSMD8
3 Cross references
213 Possible Orthologues:

Proteasome Subunit Beta Type-5-Like

Ensembl ID : ENSECRG00000012296
Gene Symbol: LOC114645856
3 Cross references
224 Possible Orthologues:

Proteasome Subunit Beta Type-7-Like

Ensembl ID : ENSECRG00000004246
Gene Symbol: LOC114651256
3 Cross references
172 Possible Orthologues:

Proteasome Subunit Beta Type-8-Like

Ensembl ID : ENSECRG00000014016
Gene Symbol: LOC114669382
3 Cross references
214 Possible Orthologues:

Proteasome Subunit Beta Type-8-Like

Ensembl ID : ENSECRG00000004720
Gene Symbol: LOC114651617
3 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).